Spots Global Cancer Trial Database for Wormwood in Chronic Progressive Disorders With Reduced Appetite
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Wormwood in Chronic Progressive Disorders With Reduced Appetite
Official Title: Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age
Study ID: NCT01126931
Conditions
Interventions
Study Description
Brief Summary: Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer. Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite
Detailed Description: Supplementation with wormwood in chronic disorders associated with reduced appetite. Examples: 1. Cancer 2. Autoimmune diseases such as Crohns disease and IgA Nephropathy 3. Old age 4. Chronic stress and depression
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Freiburg, Medical Faculty, Freiburg, Baden, Germany
Contact Details
Name: Simone S Krebs, MD, PhD
Affiliation: University of Freiburg, Nuclear Medicine, Germany
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
